VRS
RVMD icon

Virginia Retirement Systems’s Revolution Medicines RVMD Stock Holding History

Virginia Retirement Systems’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,900
Closed -$311K – 1044
2025
Q4 		$311K Buy
+3,900
New +$256K ﹤0.01% 846
2023
Q3 		– Sell
-10,900
Closed -$292K – 1022
2023
Q2 		$292K Sell
10,900
-7,800
-42% -$191K ﹤0.01% 844
2023
Q1 		$405K Buy
18,700
+3,600
+24% +$88.6K ﹤0.01% 798
2022
Q4 		$360K Sell
15,100
-11,200
-43% -$238K ﹤0.01% 919
2022
Q3 		$519K Buy
+26,300
New +$578K 0.01% 794
2022
Q1 		$337K Buy
+13,200
New +$287K ﹤0.01% 950

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Virginia Retirement Systems's RVMD Position: Q1 2026 in Review

Virginia Retirement Systems sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 3,900 shares — an estimated $311K sold.

Virginia Retirement Systems first reported a position in RVMD in Q1 2022 and held it in 6 quarters. The position peaked at $519K in Q3 2022. 514 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Virginia Retirement Systems reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • Virginia Retirement Systems sold 3,900 Revolution Medicines shares in Q1 2026, an estimated $311K.
  • Virginia Retirement Systems first reported a position in Revolution Medicines in Q1 2022 and held it in 6 quarters.
  • Virginia Retirement Systems's Revolution Medicines position peaked at $519K in Q3 2022.
  • 514 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Virginia Retirement Systems's 13F filing for Q1 2026, filed 25 Aug 2026.